A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2010

Este artículo no está incluido en ninguna revisión sistemática

Cargando información sobre las referencias
A open-label, multi-center 2-year safety study to ascertain the baseline levels of bone marrow fibers in previously treated adults with chronic immune (idiopathic) thrombocytopenic purpura (ITP) and to evaluate the long-term effect of eltrombopag on bone marrow fibers. The study will also describe the long-term safety and tolerability of oral eltrombopag treatment in subjects with chronic ITP.
Epistemonikos ID: 902dbb0acc112c7cc606ff08934a29d1dbfcd4b4
First added on: May 05, 2024